Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
2014 6
2015 3
2016 2
2017 2
2018 1
2019 4
2020 2
2021 4
2022 10
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean boyce r[au] (427 results)?
A Comprehensive Review of Ixekizumab Efficacy in Nail Psoriasis from Clinical Trials for Moderate-to-Severe Psoriasis and Psoriatic Arthritis.
Kirkham BW, Egeberg A, Behrens F, Pinter A, Merola JF, Holzkämper T, Gallo G, Ng KJ, Bolce R, Schuster C, Nash P, Puig L. Kirkham BW, et al. Among authors: bolce r. Rheumatol Ther. 2023 Oct;10(5):1127-1146. doi: 10.1007/s40744-023-00553-1. Epub 2023 Jul 3. Rheumatol Ther. 2023. PMID: 37400681 Free PMC article. Review.
Real-world treatment patterns and use of adjunctive pain and anti-inflammatory medications among patients with psoriatic arthritis treated with IL-17A inhibitors in the United States.
Pizzicato LN, Vadhariya A, Birt J, Ketkar AG, Bolce R, Grabner M, Pepe RS, Walsh JA. Pizzicato LN, et al. Among authors: bolce r. J Manag Care Spec Pharm. 2023 Jan;29(1):24-35. doi: 10.18553/jmcp.2022.22144. Epub 2022 Nov 1. J Manag Care Spec Pharm. 2023. PMID: 36318701 Free PMC article.
Association of the clinical components in the distal interphalangeal joint synovio-entheseal complex and subsequent response to ixekizumab or adalimumab in psoriatic arthritis.
McGonagle D, Kavanaugh A, McInnes IB, Kristensen LE, Merola JF, Strober B, Bolce R, Lisse J, Pustizzi J, Sapin C, Ritchlin C. McGonagle D, et al. Among authors: bolce r. Rheumatology (Oxford). 2024 Feb 10:keae060. doi: 10.1093/rheumatology/keae060. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38341669
Ixekizumab in radiographic axial spondyloarthritis with and without elevated C-reactive protein or positive magnetic resonance imaging.
Maksymowych WP, Bolce R, Gallo G, Seem E, Geneus VJ, Sandoval DM, Østergaard M, Tada K, Baraliakos X, Deodhar A, Gensler LS. Maksymowych WP, et al. Among authors: bolce r. Rheumatology (Oxford). 2022 Nov 2;61(11):4324-4334. doi: 10.1093/rheumatology/keac104. Rheumatology (Oxford). 2022. PMID: 35188180 Free PMC article. Clinical Trial.
Baseline Characteristics and Treatment Response to Ixekizumab Categorised by Sex in Radiographic and Non-radiographic Axial Spondylarthritis Through 52 Weeks: Data from Three Phase III Randomised Controlled Trials.
van der Horst-Bruinsma IE, de Vlam K, Walsh JA, Bolce R, Hunter T, Sandoval D, Zhu D, Geneus V, Soriano ER, Magrey M. van der Horst-Bruinsma IE, et al. Among authors: bolce r. Adv Ther. 2022 Jun;39(6):2806-2819. doi: 10.1007/s12325-022-02132-2. Epub 2022 Apr 16. Adv Ther. 2022. PMID: 35429281 Free PMC article. Clinical Trial.
37 results